T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KTWO
1226
DELISTED
K2M Group Holdings, Inc
KTWO
| $13.8M | ﹤0.01% |
+927,650
| New | +$13.9M |
|
1227
Best Buy
BBY
$18.4B
| $13.8M | ﹤0.01% |
444,199
+26,125
| +6% | +$704K |
|
|
UBNK
1228
DELISTED
United Financial Bancorp, Inc.
UBNK
| $13.8M | ﹤0.01% |
1,015,526
+992,034
| +4,223% | +$13.3M |
|
1229
Skyworks Solutions
SWKS
$10.5B
| $13.7M | ﹤0.01% |
291,816
-22,013
| -7% | -$927K |
|
|
AENZ
1230
DELISTED
Aenza S.A.A.
AENZ
| $13.7M | ﹤0.01% |
252,957
-28,343
| -10% | -$1.45M |
|
1231
Altisource Portfolio Solutions
ASPS
$65.6M
| $13.6M | ﹤0.01% |
14,788
+888
| +6% | +$792K |
|
|
FRF
1232
DELISTED
FORTEGRA FINL CORP COM STK (DE)
FRF
| $13.5M | ﹤0.01% |
1,766,986
+8,800
| +0.5% | +$62.1K |
|
1233
Skywest
SKYW
$4.2B
| $13.4M | ﹤0.01% |
1,099,120
-5,000
| -0.5% | -$60.7K |
|
|
TOUR
1234
Tuniu
TOUR
$54.4M
| $13.4M | ﹤0.01% |
+76,182
| New | +$11.4M |
|
|
GTAT
1235
DELISTED
GT ADVANCED TECHNOLOGIES INC COM STK (DE)
GTAT
| $13.4M | ﹤0.01% |
721,740
-242,220
| -25% | -$4M |
|
1236
Goodyear
GT
$1.78B
| $13.4M | ﹤0.01% |
482,806
+61,430
| +15% | +$1.6M |
|
1237
Crocs
CROX
$6.35B
| $13.4M | ﹤0.01% |
892,301
+868,801
| +3,697% | +$12.9M |
|
1238
Prestige Consumer Healthcare
PBH
$2.4B
| $13.4M | ﹤0.01% |
395,700
+27,300
| +7% | +$874K |
|
1239
Infosys
INFY
$49.4B
| $13.3M | ﹤0.01% |
1,985,672
-705,280
| -26% | -$4.69M |
|
|
NE
1240
DELISTED
Noble Corporation
NE
| $13.3M | ﹤0.01% |
454,923
+12,927
| +3% | +$355K |
|
|
HPY
1241
DELISTED
HEARTLAND PAYMENT SYSTEMS, INC. COM STK
HPY
| $13.3M | ﹤0.01% |
323,335
+23,200
| +8% | +$944K |
|
1242
Arista Networks
ANET
$253B
| $13.3M | ﹤0.01% |
+3,407,040
| New | +$13.7M |
|
|
VAR
1243
DELISTED
Varian Medical Systems, Inc.
VAR
| $13.3M | ﹤0.01% |
181,982
-10,720
| -6% | -$770K |
|
1244
Tootsie Roll Industries
TR
$3.04B
| $13.2M | ﹤0.01% |
640,589
+6,271
| +1% | +$126K |
|
|
AOI
1245
DELISTED
Alliance One International
AOI
| $13.2M | ﹤0.01% |
528,420
-2,250
| -0.4% | -$59.3K |
|
1246
FIVE9
FIVN
$2.44B
| $13.2M | ﹤0.01% |
+1,833,660
| New | +$12.9M |
|
1247
Sally Beauty Holdings
SBH
$1.55B
| $13.1M | ﹤0.01% |
524,200
+27,600
| +6% | +$713K |
|
|
WBMD
1248
DELISTED
WebMD Health Corp.
WBMD
| $13M | ﹤0.01% |
269,970
+24,200
| +10% | +$1.06M |
|
1249
Expedia Group
EXPE
$39.9B
| $12.9M | ﹤0.01% |
163,937
+890
| +0.5% | +$64.9K |
|
|
SHLD
1250
DELISTED
Sears Holding Corporation
SHLD
| $12.9M | ﹤0.01% |
345,437
-80,399
| -19% | -$2.97M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.